Search

Your search keyword '"Garcia-Basteiro, Al"' showing total 83 results

Search Constraints

Start Over You searched for: Author "Garcia-Basteiro, Al" Remove constraint Author: "Garcia-Basteiro, Al"
83 results on '"Garcia-Basteiro, Al"'

Search Results

1. A Global Tuberculosis Dictionary: unified terms and definitions for the field of tuberculosis

2. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019

3. Clinical standards for the diagnosis, treatment and prevention of TB infection

4. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis

5. Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding

6. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

7. Contaminant DNA in bacterial sequencing experiments is a major source of false genetic variability

8. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

9. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

10. Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis

11. The burden of disease in Spain: Results from the Global Burden of Disease 2016

12. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015

13. Trends in HIV/AIDS morbidity and mortality in Eastern Mediterranean countries, 1990–2015: findings from the Global Burden of Disease 2015 study

14. Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015: findings from the Global Burden of Disease 2015 study

15. Current use and acceptability of novel diagnostic tests for active tuberculosis: A worldwide survey|Uso atual e aceitabilidade de novos testes diagnósticos para tuberculose ativa: Um inquérito mundial

16. Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates

17. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015

18. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016

19. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

20. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

21. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

22. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

23. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

24. BMI as a predictor of progression from TB infection to active TB in PLHIV.

25. Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis.

27. Implications of subclinical tuberculosis for vaccine trial design and global effect.

28. Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial).

30. Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy study.

31. Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: an individual patient data meta-analysis.

32. What is next for BCG revaccination to prevent tuberculosis?

33. Incarceration and TB: the epidemic beyond prison walls.

34. Reply to McShane.

35. Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE).

36. Excess tuberculosis risk during and following incarceration in Paraguay: a retrospective cohort study.

39. An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine Trials.

40. Implementation of WHO guidelines on urine lateral flow LAM testing in high TB/HIV burden African countries.

41. Management of advanced HIV disease in Africa.

42. Lots of considerations when evaluating the FujiLAM assay.

43. Initiation and adherence to isoniazid preventive therapy in children under 5 years of age in Manhiça, Southern Mozambique.

44. Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel.

46. Prevalence and clinical characteristics of pulmonary TB among pregnant and post-partum women.

47. End-point definition and trial design to advance tuberculosis vaccine development.

48. ERS International Congress 2021: highlights from the Respiratory Infections Assembly.

49. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.

50. Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?

Catalog

Books, media, physical & digital resources